Sign in
Not yet recruitingPhase 2

Acetylcholinesterase Inhibitor in Anorexia Nervosa: Multicenter, Double-Blind, Placebo-Controlled Trial

Key facts

Who runs it
Centre Hospitalier St Anne
Where
France3 sites in 1 countryChoose a country to see its sites
Status
Not yet recruiting
Phase
Phase 2
People taking part
147 people, planned
Started
Nov 2024
Expected to end
May 2030
Type of study
Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Donepezil 2.5 mg
  • Donepezil 5 mg
  • Placebo Comparator
Record updated
14 November 2024

Who can take part

Age
18 years to 65 years
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 27 criteriaShow less

Who can take part

  • Female
  • Presence of the 3 DSM-V criteria for Anorexia Nervosa
  • Restrictive subtype of Anorexia Nervosa according to DSM-5
  • Body Mass Index between 15 and 18.5 kg/m²
  • Aged 18 to 65 years
  • Resting heart rate \> or = 40 bpm
  • Use of a highly effective contraceptive method
  • Affiliation or entitlement to a Health Insurance scheme
  • Prior free, informed, and written consent

Who cannot take part

  • History of peptic ulcer disease or concurrent treatment with non-steroidal anti-inflammatory drugs
  • Current or recent (within three weeks prior to inclusion) psychotropic treatment (including antidepressants, to avoid interaction/potentiation in this population)
  • Known hypersensitivity to donepezil hydrochloride, piperidine derivatives, or any excipients of the investigational drug
  • Past diagnosis of binge-eating disorder
  • Associated diagnosis of schizophrenia and/or persistent delusional disorder and/or bipolar disorder
  • History of asthma or obstructive bronchopulmonary disease
  • History of epileptic disorders
  • Renal insufficiency (glomerular filtration rate less than 60 mL/min according to the MDRD formula)
  • Conductance disorder characterized by electrocardiogram
  • Hepatic insufficiency or transaminase levels greater than 5 times the normal upper limit
  • QTc according to Bazett's formula greater than 480 ms on electrocardiogram
  • Presence of one or more somatic criteria for hospitalization according to french HAS 2010 guidelines
  • Past diagnosis of anorexia nervosa with binge-eating/purging type
  • Past diagnosis of bulimia nervosa
  • Treatment involving the following cytochromes: P450, P3A4, P2D6
  • Pregnant or breastfeeding woman
  • Person under legal protection measures
  • Person under guardianship measures

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn if the daily take of donepezil can treat adult patient suffering from anorexia nervosa. The main question it aims to answer is : do daily donepezil intake permit weight gain and reduction of food restriction rituals ? The treatment is a capsule comprising a drug limiting the degradation of a neurotransmitter called acetylcholine. This treatment has long been used to treat certain cognitive disorders. Researchers will compare two drug dosage and a look-alike capsule that contains no drug to see if the dose has an impact on the effect. Participants will take one capsule per day for three months will have regular hospital visits for cognitive and metabolic tests.

The 3 groups in the trial

  • donepezil 2.5 mgTreatment being tested

    donepezil 2.5 mg daily for 90 days

  • donepezil 5 mgTreatment being tested

    donepezil 5 mg daily for 90 days

  • placeboPlacebo, for comparison

    placebo daily for 90 days

    Treatment: Placebo Comparator

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov and on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Acetylcholinesterase Inhibitor Treatment in Anorexia Nervosa: a Multicenter, Double-Blind, Placebo-Controlled Randomized Trial
Fit questions
Built from NCT06687993, who can take part
Record updated
14 November 2024